The DOI matches its Crossref record; 112 of the 113 references it cites were found in a registry or an index.
Targeting HMGB1 in inflammation
Open accessAbstract
High mobility group box 1 (HMGB1), a highly conserved, ubiquitous protein present in the nuclei and cytoplasm of nearly all cell types, is a necessary and sufficient mediator of inflammation during sterile and infection-associated responses. Elevated levels of HMGB1 in serum and tissues occur during sterile tissue injury and during infection, and targeting HMGB1 with antibodies or specific antagonists is protective in established preclinical inflammatory disease models including lethal endotoxemia or sepsis, collagen-induced arthritis, and ischemia-reperfusion induced tissue injury. Future advances in this field will stem from understanding the biological basis for the success of targeting HMGB1 to therapeutic improvement in the treatment of inflammation, infection and ischemia-reperfusion induced injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Past research conducted on peripheral immune cells demonstrates that HMGB-1 is a potent proinflammatory signaling molecule that is released under inflammatory conditions, including sepsis and ischemia (Yang and Tracey, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Yang and Tracey, 2009
In the citing paper
“Typically, neuronal release of HMGB-1 occurs during necrotic conditions, such as ischemia (Yang and Tracey, 2009) and sepsis (Yang et al, 2004).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Yang and Tracey, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Self-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Self-citationSecretory products of macrophages.
Nathan, C. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112815 · Cited by 2,615
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
Physiology and immunology of the cholinergic antiinflammatory pathway
Tracey, K. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30555 · Cited by 1,563
Self-citationAndersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Self-citationMonocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., et al. (2004) · Nature Medicine · doi:10.1038/nm1124 · Cited by 1,170
Self-citation
Flagged first, then by citations
1 of the 113 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- [4]Dinarello CA Interleukin-1 family Thomson AW Lotze MT Cytokine Handbook 4 Academic Press 2003 643 662
- [5]Kishmoto T Interleukin 6 Thomson AW Lotze MT Cytokine Handbook 4 1 Academic Press 2003 281 295
- [30]Kaczorowski DJ Tsung A Billiar TR Innate immune mechanisms in ischemia/reperfusion Front Biosci (Elite Ed) 1 2009 91 98 19482628
- [43]Yang H Wang H Ochani M Ochani K Rosas-Ballina M Parrish WR Tracey KJ Endogenous mammalian HMGB1, devoid of any contaminants introduced by purification of recombinant proteins, mediates anorexia, weight loss, and increased TNF levels 31st Annual Conference on Shock Cologne, Germany, Shock 29 2008 Supp 91
Cited by
Sorted by citations
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,479
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y., Zhang, H., Pang, X., Chen, L., Zhou, L., Chen, M., Tian, D., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 997
Yang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lü, B., Chavan, S. S., Rosas‐Ballina, M., Al‐Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 812
Self-citationTargeting Inflammation Driven by HMGB1
Yang, H., Wang, H., & Andersson, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00484 · Cited by 662
Self-citationYang, H., Antoine, D. J., Andersson, U., & Tracey, K. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212662 · Cited by 542
Self-citationHost innate immune responses to sepsis
Wiersinga, W. J., Leopold, S. J., Cranendonk, D. R., & van der Poll, T. (2013) · Virulence · doi:10.4161/viru.25436 · Cited by 488
Ceulemans, A.-G., Zgavc, T., Kooijman, R., Hachimi-Idrissi, S., Sarre, S., & Michotte, Y. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-74 · Cited by 351
Paudel, Y. N., Shaikh, M. F., Chakraborti, A., Kumari, Y., Aledo-Serrano, Á., Aleksovska, K., Alvim, M. K. M., & Othman, I. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00628 · Cited by 311
Kim, J., Kim, H., & Park, S. B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508343a · Cited by 309
Current trends in inflammatory and immunomodulatory mediators in sepsis
Aziz, M., Jacob, A., Yang, W.-L., Matsuda, A., & Wang, P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912437 · Cited by 314
Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
Kawanishi, S., Ohnishi, S., Ma, N., Hiraku, Y., & Murata, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081808 · Cited by 289
Rosin, D. L., & Okusa, M. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040430 · Cited by 292
Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal
Weber, M. D., Godbout, J. P., & Sheridan, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.102 · Cited by 283
TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives
Tammaro, A., Derive, M., Gibot, S., Leemans, J. C., Florquin, S., & Dessing, M. C. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.043 · Cited by 253
Parker, K. H., Sinha, P., Horn, L. A., Clements, V. K., Yang, H., Li, J., Tracey, K. J., & Ostrand‐Rosenberg, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2347 · Cited by 251
Self-citationWeber, M. D., Frank, M. G., Tracey, K. J., Watkins, L. R., & Maier, S. F. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3561-14.2015 · Cited by 215
“Importantly, HMGB-1 has been reported to be present in the CNS and to mediate neuroinflammatory responses to ischemia and other injuries (Yang and Tracey, 2009).”
Self-citationDamage-associated molecular patterns in trauma
Relja, B., & Land, W. G. (2019) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-019-01235-w · Cited by 225
Molecular and cellular paradigms of multidrug resistance in cancer
Vaidya, F. U., Chhipa, A. S., Mishra, V., Gupta, V. K., Rawat, S. G., Kumar, A., & Pathak, C. (2020) · Cancer Reports · doi:10.1002/cnr2.1291 · Cited by 215
He, H., Wang, Y., Le, Y., Duan, K., Yan, X., Liao, Q., Liao, Y., Tong, J., Terrando, N., & Ouyang, W. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12018 · Cited by 194
Critical role of RAGE and HMGB1 in inflammatory heart disease
Bangert, A., Andrassy, M., Müller, A., Bockstahler, M., Fischer, A., Volz, C. H., Leib, C., Göser, S., Korkmaz‐Icöz, S., Zittrich, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522288113 · Cited by 173
High-mobility group box family of proteins: ligand and sensor for innate immunity
Yanai, H., Ban, T., & Taniguchi, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.005 · Cited by 146
Ge, X., Arriazu, E., Magdaleno, F., Antoine, D. J., Cruz, R. D., Theise, N. D., & Nieto, N. (2018) · Hepatology · doi:10.1002/hep.30093 · Cited by 142
Necrotic cell death in atherosclerosis
Martinet, W., Schrijvers, D. M., & Meyer, G. R. Y. D. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0192-x · Cited by 139
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 146
The Alarmin HMGB1 Mediates Age-Induced Neuroinflammatory Priming
Fonken, L. K., Frank, M. G., Kitt, M. M., D'Angelo, H. M., Norden, D. M., Weber, M. D., Barrientos, R. M., Godbout, J. P., Watkins, L. R., & Maier, S. F. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1161-16.2016 · Cited by 139
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation
Lee, S., Nam, Y., Koo, J. Y., Lim, D., Park, J., Ock, J., Kim, J., Suk, K., & Park, S. B. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1669 · Cited by 139
Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo
Yoo, H., Ku, S., Baek, Y.-D., & Bae, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0689-x · Cited by 132
Kirkman, E., Watts, S. A., & Cooper, G. J. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0240 · Cited by 125
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes
Yang, H., Wang, H., Levine, Y. A., Gunasekaran, M., Wang, Y., Addorisio, M. E., Zhu, S., Li, W., Li, J., de Kleijn, D. P. V., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85375 · Cited by 123
Self-citationSepsis: Something old, something new, and a systems view
Namas, R. A., Zamora, R., Namas, R. A., An, G. C., Doyle, J. C., Dick, T. E., Jacono, F. J., Androulakis, I. P., Nieman, G. F., Chang, S., et al. (2011) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.05.025 · Cited by 123
The dual role and therapeutic potential of high-mobility group box 1 in cancer
He, S.-J., Cheng, J. Q., Xiao, F., Yu, Y., Tian, L., & Huang, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.17885 · Cited by 126
Thankam, F. G., Roesch, Z. K., Dilisio, M. F., Radwan, M. M., Kovilam, A. N., Gross, R. M., & Agrawal, D. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-27250-2 · Cited by 121
Su, X., Wang, H., Zhao, J., Pan, H., & Mao, L. (2011) · Mediators of Inflammation · doi:10.1155/2011/807142 · Cited by 120
Lewis, D. H., Chan, D. L., Pinheiro, D., Armitage‐Chan, E. A., & Garden, O. A. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00905.x · Cited by 125
NMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury
Xiahou, Z., Wang, X., Shen, J., Zhu, X., Feng, X., Hu, R., Guo, D., Li, H., Tian, Y., Liu, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00930-9 · Cited by 116
Vitali, R., Stronati, L., Negroni, A., Nardo, G. D., Pierdomenico, M., Giudice, E. D., Rossi, P., & Cucchiara, S. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.231 · Cited by 117
Paudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., & Shaikh, M. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134609 · Cited by 118
Rickenbacher, A., Jang, J. H., Limani, P., Ungethüm, U., Lehmann, K., Oberkofler, C. E., Weber, A., Graf, R., Humar, B., & Clavien, P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.010 · Cited by 111
Ambient Particulate Air Pollution and MicroRNAs in Elderly Men
Fossati, S., Baccarelli, A., Zanobetti, A., Hoxha, M., Vokonas, P., Wright, R. O., & Schwartz, J. D. (2013) · Epidemiology · doi:10.1097/ede.0000000000000026 · Cited by 110
Dual Role of Toll-Like Receptors in Asthma and Chronic Obstructive Pulmonary Disease
Bezemer, G. F. G., Sagar, S., van Bergenhenegouwen, J., Georgiou, N., Garssen, J., Kraneveld, A. D., & Folkerts, G. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004622 · Cited by 110
High‐Mobility Group Box‐1 and Liver Disease
Gaskell, H., Ge, X., & Nieto, N. (2018) · Hepatology Communications · doi:10.1002/hep4.1223 · Cited by 104
Anti-Inflammatory Effects of Hyperoside in Human Endothelial Cells and in Mice
Ku, S., Zhou, W. P., Lee, W., Han, M. S., Na, M., & Bae, J. (2014) · Inflammation · doi:10.1007/s10753-014-9989-8 · Cited by 101
Kong, Z.-H., Chen, X., Hua, H.-P., Liang, L., & Liu, L.-J. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0989-7 · Cited by 99
Tu, C., Yao, Q., Xu, B., Wang, J., Zhou, C.-H., & Zhang, S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.05.050 · Cited by 98
Interactions between tumor-derived proteins and Toll-like receptors
Jang, G.-Y., Lee, J., Kim, Y. S., Lee, S., Han, H. D., Hong, K., Kang, T. H., & Park, Y. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00540-4 · Cited by 98
Weber, M. D., Frank, M. G., Sobesky, J. L., Watkins, L. R., & Maier, S. F. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.03.004 · Cited by 93
Stress and aging act through common mechanisms to elicit neuroinflammatory priming
Fonken, L. K., Frank, M. G., Gaudet, A. D., & Maier, S. F. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.07.012 · Cited by 98
Smoking and Endothelial Dysfunction
Golbidi, S., Edvinsson, L. I., & Laher, I. (2018) · Current Vascular Pharmacology · doi:10.2174/1573403x14666180913120015 · Cited by 97
Rump, K., & Adamzik, M. (2022) · Cells · doi:10.3390/cells11192954 · Cited by 96
Hu, Y., Pai, M., Yeh, C., Hou, Y., & Yeh, S. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00246.2011 · Cited by 88
Inflammation-induced DNA damage and damage-induced inflammation: a vicious cycle
Palmai‐Pallag, T., & Bachrati, C. Z. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.10.001 · Cited by 88
Stanzione, R., Forte, M., Cotugno, M., Bianchi, F., Marchitti, S., & Rubattu, S. D. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00966-4 · Cited by 88
The Multitasking Potential of Alarmins and Atypical Chemokines
Kapurniotu, A., Gökçe, Ö., & Bernhagen, J. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00003 · Cited by 85
HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17‐cell expansion
Su, Z., Sun, C., Zhou, C., Liu, Y., Zhu, H., Sandoghchian, S., Zheng, D., Peng, T., Zhang, Y., Jiao, Z., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141879 · Cited by 81
The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy
Smolarczyk, R., Cichoń, T., Matuszczak, S., Mitrus, I., Lesiak, M., Kobusińska, M., Kamysz, W., Jarosz–Biej, M., Sieroń, A. L., & Szala, S. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0183-0 · Cited by 80
Hydrogen Gas Presents a Promising Therapeutic Strategy for Sepsis
Xie, K., Liu, L., Yu, Y., & Wang, G. (2014) · BioMed Research International · doi:10.1155/2014/807635 · Cited by 79
TREM-1 Modulation Strategies for Sepsis
Siskind, S., Brenner, M., & Wang, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907387 · Cited by 76
Huang, B., Sikorski, R. P., Kirn, D. H., & Thorne, S. H. (2010) · Gene Therapy · doi:10.1038/gt.2010.121 · Cited by 76
High glucose induces and activates Toll-like receptor 4 in endothelial cells of diabetic retinopathy
Wang, L., Wang, J., Fang, J., Zhou, H., Liu, X., & Su, S. B. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0086-4 · Cited by 77
Rao, Y., Wan, Q., Su, H., Xiao, X., Liao, Z., Ji, J., Yang, C., Lin, L., & Su, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003840 · Cited by 76
Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
Zickert, A., Palmblad, K., Sundelin, B., Chavan, S. S., Tracey, K. J., Bruchfeld, A. N., & Gunnarsson, I. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3747 · Cited by 75
Self-citationp53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release
Yan, H., Wu, H., Zhang, H., Ashton, C., Tong, C., Wu, H., Qian, Q., Wang, H.-Y., & Ying, Q. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.029 · Cited by 76
Díaz-Dinamarca, D. A., Salazar, M. L., Castillo, B. N., Manubens, A., Vasquez, A. E., Salazar, F., & Becker, M. I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081671 · Cited by 75
Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer
Ohmori, H., Luo, Y., & Kuniyasu, H. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.546785 · Cited by 72
Anti-inflammatory activities of oleanolic acid on HMGB1 activated HUVECs
Yang, E. J., Lee, W., Ku, S., Song, K., & Bae, J. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.02.026 · Cited by 70
Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro
Kim, D.-C., Lee, W., & Bae, J. (2011) · Inflammation Research · doi:10.1007/s00011-011-0381-y · Cited by 70
Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS
Garg, D., & Merhi, Z. O. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0205-6 · Cited by 73
Papatheodorou, A., Stein, A., Bank, M. A., Sison, C. P., Gibbs, K., Davies, P., & Bloom, O. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4596 · Cited by 67
IL ‐33 and HMGB 1 alarmins: sensors of cellular death and their involvement in liver pathology
Arshad, M. I., Piquet‐Pellorce, C., & Samson, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02802.x · Cited by 70
High-mobility group box 1 protein and its role in severe acute pancreatitis
Shen, X. L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i5.1424 · Cited by 61
Effects of dexmedetomidine on early and late cytokines during polymicrobial sepsis in mice
Xu, L. N., Bao, H., Si, Y., & Wang, X. (2013) · Inflammation Research · doi:10.1007/s00011-013-0604-5 · Cited by 57
Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice
Lee, W., Ku, S., Na, D. H., & Bae, J. (2015) · Inflammation · doi:10.1007/s10753-015-0171-8 · Cited by 58
Alarmins and Antitumor Immunity
Nie, Y., Yang, D., & Oppenheim, J. J. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.021 · Cited by 57
Aikawa, E., Fujita, R., Kikuchi, Y., Kaneda, Y., & Tamai, K. (2015) · Scientific Reports · doi:10.1038/srep11008 · Cited by 60
The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer
Feng, A., Tu, Z., & Yin, B. (2016) · Oncotarget · doi:10.18632/oncotarget.7050 · Cited by 57
Relja, B., Mörs, K., & Marzi, İ. (2018) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-018-0962-3 · Cited by 57
Wei, L., Zhang, W., Li, Y., & Zhai, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.986511 · Cited by 60
Sapojnikova, N. A., Kartvelishvili, T., Asatiani, N. V., Zinkevich, V., Kalandadze, I., Gugutsidze, D., Shakarishvili, R., & Tsiskaridze, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.031 · Cited by 56
Kinfe, T. M., Muhammad, S., Link, C., Roeske, S., Chaudhry, S. R., & Yearwood, T. L. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12586 · Cited by 56
Orientin Inhibits HMGB1-Induced Inflammatory Responses in HUVECs and in Murine Polymicrobial Sepsis
Yoo, H., Ku, S., Lee, T., & Bae, J. (2014) · Inflammation · doi:10.1007/s10753-014-9899-9 · Cited by 55
The immune response to severe bacterial infections: consequences for therapy
Giamarellos‐Bourboulis, E. J., & Raftogiannis, M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.2 · Cited by 55
Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice
Vitali, R., Palone, F., Cucchiara, S., Negroni, A., Cavone, L., Costanzo, M., Aloi, M., Dilillo, A., & Stronati, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066527 · Cited by 55
Liu, A., Fang, H., Dirsch, O., Jin, H., & Dahmen, U. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035379 · Cited by 52
Aslani, F., Schuppe, H., Guazzone, V. A., Bhushan, S., Wahle, E., Lochnit, G., Lustig, L., Meinhardt, A., & Fijak, M. (2014) · Human Reproduction · doi:10.1093/humrep/deu320 · Cited by 54
Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma
Manganelli, V., Signore, M., Pacini, I., Misasi, R., Tellan, G., Garofalo, T., Lococo, E., Chirletti, P., Sorice, M., & Delogu, G. (2010) · Critical Care · doi:10.1186/cc9316 · Cited by 55
Wang, W., Chen, X., Zhang, J., Zhao, Y., Li, S., Tan, L., Gao, J., Fang, X., & Luo, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.001 · Cited by 53
Wang, Z., Chen, W., Li, Y., Zhang, S., Lou, H., Lu, X., & Fan, X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113783 · Cited by 53
Inhibitory effects of kaempferol-3-O-sophoroside on HMGB1-mediated proinflammatory responses
Kim, T. H., Ku, S., & Bae, J. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.12.004 · Cited by 52
Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock
Barnay‐Verdier, S., Fattoum, L., Borde, C., Kaveri, S. V., Gibot, S., & Maréchal, V. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2192-6 · Cited by 51
Postoperative cognitive dysfunction is made persistent with morphine treatment in aged rats
Muscat, S. M., Deems, N. P., D’Angelo, H. M., Kitt, M. M., Grace, P. M., Andersen, N. D., Silverman, S. N., Rice, K. C., Watkins, L. R., Maier, S. F., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.11.008 · Cited by 50
Role of macrophage-derived hypoxia-inducible factor (HIF)-1α as a mediator of vascular remodelling
Nakayama, T., Kurobe, H., Sugasawa, N., Kinoshita, H., Higashida, M., Matsuoka, Y., Yoshida, Y., Hirata, Y., Sakata, M., Maxfield, M. W., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt146 · Cited by 50
Fei, Y.-X., Zhao, B., Yin, Q., Qiu, Y.-Y., Ren, G., Wang, B., Wang, Y.-F., Fang, W., & Li, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01361 · Cited by 50
Cho, W., Koo, J. Y., Park, Y., Oh, K., Lee, S., Song, J.-S., Bae, M. A., Lim, D., Lee, D., & Park, S. B. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00954 · Cited by 49
Forsythoside B Protects Against Experimental Sepsis by Modulating Inflammatory Factors
Jiang, W., YongXu, Zhang, S., Zhu, H., & Jian‐Hou (2011) · Phytotherapy Research · doi:10.1002/ptr.3668 · Cited by 48
Zhang, F., Huang, G., Hu, B., Fang, L.-P., Cao, E.-H., Xin, X., Song, Y., & Shi, Y. P. (2014) · Mediators of Inflammation · doi:10.1155/2014/257930 · Cited by 48
Shimizu, S., Kouzaki, H., Kato, T., Tojima, I., & Shimizu, T. (2016) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2016.30.4300 · Cited by 47
HMGB1 Protein Does Not Mediate the Inflammatory Response in Spontaneous Spinal Cord Regeneration
Dong, Y., Gu, Y., Huan, Y., Wang, Y., Liu, Y., Liu, M., Ding, F., Gu, X., & Wang, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463810 · Cited by 46
Ieong, C., Sun, H.-G., Wang, Q., & Ma, J. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.10.034 · Cited by 46
Rosenberg, J. H., Rai, V., Dilisio, M. F., Sekundiak, T. D., & Agrawal, D. K. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3078-x · Cited by 45
Metadata
- Authors
- Yang, H., & Tracey, K. J.
- Affiliations
- Feinstein Institute for Medical Research (US)
- Corresponding author
- Yang, Huan
- Venue
- Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 1799
- Issue
- 1-2
- Pages
- 149-156
- ISSN
- 1874-9399 (ISSN-L)
- PMC
- PMC4533842
- OpenAlex
- W1983348216
- Cited by
- 351
- References
- 113
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 4 · 2023: 9 · 2022: 24 · 2021: 20 · 2020: 28 · 2019: 14 · 2018: 24 · 2017: 25 · 2016: 23 · 2015: 27 · 2014: 34 · 2013: 23 · 2012: 34
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM062508)
- National Center for Research Resources (MOL RR018535, M01RR018535)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
- Keywords
- HMGB1, high mobility group box 1, inflammation, infection, endotoxemia, sepsis, collagen-induced arthritis, ischemia-reperfusion injury, inflammatory disease therapy
- MeSH terms
- Animals, Disease, Humans, Immunity, Inflammation, Receptors, Immunologic, Cytokines, HMGB1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review